Franklin Resources Inc Biotechnology

Franklin Resources Inc

$378 Billion
Q3 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
PRTA Prothena Corp Public LTD CO	$481M	$597,000 0.0% of portfolio	61,172	Q3 2025 Added 9.08%
XNCR Xencor Inc	$891M	$524,000 0.0% of portfolio	44,680	Q3 2025 Reduced 0.01%
TECH Bio Techne Corp	$2.33B	$523,000 0.0% of portfolio	9,417	Q3 2025 Reduced 20.17%
FULC Fulcrum Therapeutics, Inc.	$451M	$523,000 0.0% of portfolio	60,022	Q2 2025 Added 141.82%
BEAM Beam Therapeutics Inc.	$1.55B	$518,000 0.0% of portfolio	21,382	Q3 2025 Added 11.96%
CRMD Cor Medix Inc.	$467M	$518,000 0.0% of portfolio	43,313	Q3 2025 Added 7.16%
RXRX Recursion Pharmaceuticals, Inc.	$747M	$469,000 0.0% of portfolio	96,146	Q3 2025 Added 15.2%
WVE Wave Life Sciences Ltd.	$600M	$448,000 0.0% of portfolio	62,259	Q3 2025 Added 0.45%
FOLD Amicus Therapeutics, Inc.	$2.66B	$445,000 0.0% of portfolio	56,539	Q3 2025 Added 61.56%

TRVI Trevi Therapeutics, Inc.	$661M	$445,000 0.0% of portfolio	49,878	Q3 2025 Reduced 0.08%
IONS Ionis Pharmaceuticals Inc	$10.2B	$431,000 0.0% of portfolio	6,593	Q3 2025 Added 18.66%
TSHA Taysha Gene Therapies, Inc.	$204M	$341,000 0.0% of portfolio	108,399	Q2 2025 Reduced 6.74%
REPL Replimune Group, Inc.	$443M	$340,000 0.0% of portfolio	81,234	Q3 2025 New
SANA Sana Biotechnology, Inc.	$759M	$330,000 0.0% of portfolio	93,081	Q2 2025 Added 86.78%
GLUE Monte Rosa Therapeutics, Inc.	$671M	$321,000 0.0% of portfolio	43,420	Q3 2025 Reduced 48.61%
MRVI Maravai Lifesciences Holdings, Inc.	$479M	$295,000 0.0% of portfolio	102,948	Q3 2025 Added 658.59%
RGNX Regenxbio Inc.	$498M	$278,000 0.0% of portfolio	28,871	Q3 2025 Reduced 0.79%
NRIX Nurix Therapeutics, Inc.	$603M	$268,000 0.0% of portfolio	29,077	Q3 2025 Reduced 58.97%

VERA Vera Therapeutics, Inc.	$766M	$262,000 0.0% of portfolio	9,078	Q3 2025 New
MLTX Moon Lake Immunotherapeutics	$472M	$240,000 0.0% of portfolio	33,577	Q3 2025 New
MGTX Meira G Tx Holdings PLC	$378M	$217,000 0.0% of portfolio	26,406	Q3 2025 Reduced 18.79%
IBRX Immunity Bio, Inc.	$833M	$214,000 0.0% of portfolio	87,141	Q2 2025 New
KMPH Kempharm, Inc	$170M	$181,000 0.0% of portfolio	36,835	Q3 2025 New
NTLA Intellia Therapeutics, Inc.	$661M	$176,000 0.0% of portfolio	10,239	Q3 2025 New
FENC Fennec Pharmaceuticals Inc.	$211M	$156,000 0.0% of portfolio	16,978	Q3 2025 Added 3.63%
ONCY Oncolytics Biotech Inc	$60.8M	$97,000 0.0% of portfolio	69,842	Q3 2025 Added 10.38%
GERN Geron Corp	$423M	$45,000 0.0% of portfolio	33,166	Q3 2025 New
SBTX Silverback Therapeutics, Inc.	$0	$0 0.0% of portfolio	2,398,012	Q3 2025 Added 31.13%
NUVB Nuvation Bio Inc.	$1.06B	$0 0.0% of portfolio	102	Q3 2025 Reduced 51.43%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.